Seoul
South Korea
8
2024-06-27
5
2024-07-30
These are the the leading inventors for applications assigned to L-BASE CO., LTD:
L-BASE CO., LTD based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
PHARMACEUTICAL COMPOSITION FOR ENHANCING ANTICANCER EFFECT OF ANTICANCER DRUG
#2 | 2023-05-25PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER
#3 | 2022-01-27 ✅ Patent 12,048,730 granted on 2024-07-30Pharmaceutical composition for preventing or treating cancer, containing oligopeptide as active ingredient
#4 | 2020-11-19COMPOSITION FOR AUTOPHAGY INHIBITING IN CELL, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEOPLASTIC DISEASE OR INHIBITING ANTI-CANCER AGENTS RESISTANCE CONTAINING THE SAME
#5 | 2020-03-19 ✅ Patent 10,766,926 granted on 2020-09-08Composition for autophagy inhibiting in cell, and pharmaceutical composition for preventing or treating tumor disease, or inhibiting anti-cancer agents resistance containing the same
#6 | 2018-03-29 ✅ Patent 10,716,826 granted on 2020-07-21Compositions for overcoming anti-cancer drug-resistance or compositions for anti-cancer activity employing CAGE-derived peptides
#7 | 2018-03-22 ✅ Patent 10,233,221 granted on 2019-03-19Peptide having eight amino acid sequences derived from cage and retaining anticancer activity and activity to promote anticancer drug sensitivity of anticancer drug-resistant cancer cells
#8 | 2018-03-01 ✅ Patent 10,239,924 granted on 2019-03-26Peptide having eight amino acid sequences derived from cage and retaining anticancer activity and activity to promote anticancer drug sensitivity of anticancer drug-resistant cancer cells
Also check out L-Base Co., Ltd.'s (Seoul, South Korea) applicant profile with 7 patent applications submitted.
156207 ⎘